Latest market price
13.06
+0.01+0.08%
TA
Loading chart...
Snapshot
| Index | — | P/E | 19.49 | EPS (ttm) | 0.67 | Insider Own | 11.42% | Shs Outstand | 28.65M | Perf Week | 0.46% |
| Market Cap | 374.22M | Forward P/E | 26.65 | EPS next Y | 0.49 | Insider Trans | 0.55% | Shs Float | 26.76M | Perf Month | -7.31% |
| Enterprise Value | 935.22M | PEG | — | EPS next Q | 0.09 | Short Float | 2.92% | Perf Quarter | -28.48% | ||
| Income | 21.00M | P/S | 2.99 | EPS this Y | — | Short Ratio | 2.16 | Perf Half Y | -25.84% | ||
| Sales | 125.00M | P/B | 0.90 | EPS next Y | 36.11% | ROA | 2.09% | Short Interest | 781.19K | Perf YTD | -20.46% |
| Book/sh | 14.45 | P/C | 124.74 | EPS next 5Y | — | ROE | 4.96% | 52W High | 19.17 -31.87% | Perf Year | -9.49% |
| Cash/sh | 0.10 | P/FCF | 6.34 | EPS past 3/5Y | -54.28% -37.32% | ROIC | 4.85% | 52W Low | 12.58 3.82% | Perf 3Y | -52.46% |
| Dividend Est. | 1.32 (10.11%) | EV/EBITDA | 9.74 | Sales past 3/5Y | 7.28% 9.75% | Gross Margin | 63.21% | Volatility | 2.05% 2.32% | Perf 5Y | -72.15% |
| Dividend TTM | 1.76 (13.50%) | EV/Sales | 7.48 | EPS Y/Y TTM | — | Oper. Margin | 39.10% | ATR (14) | 0.32 | Perf 10Y | -43.63% |
| Dividend Ex-Date | Aug 19, 2026 | Quick Ratio | 402.22 | Sales Y/Y TTM | 5.93% | Profit Margin | 16.85% | RSI (14) | 41.80 | Recom | 2.63 |
| Dividend Gr. 3/5Y | 2.22% 2.27% | Current Ratio | 402.22 | EPS Q/Q | 112.00% | SMA20 | -0.90% | Beta | 0.62 | Target Price | 17.00 |
| Payout | 259.50% | Debt/Eq | 1.36 | Sales Q/Q | 6.90% | SMA50 | -6.92% | Rel Volume | 0.83 | Prev Close | 13.05 |
| Employees | 35 | LT Debt/Eq | 1.36 | Earnings | Nov 03 | SMA200 | -20.31% | Avg Volume | 386.50K | Price | 13.06 |
| IPO Date | May 21, 2015 | Option/Short | Yes / Yes | EPS/Sales Surpr. | -45.45% -2.51% | Net Debt/EBITDA | 5.84 | Volume | 322,615 | Change | 0.08% |
Analyst Ratings
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Oct-09-26 | Reiterated | Truist Securities | Buy | $20 → $17 |
| Aug-06-26 | Reiterated | Piper Sandler | Neutral | $20 → $17 |
| Jul-21-26 | Reiterated | Piper Sandler | Neutral | $19 → $20 |
| Feb-19-26 | Reiterated | Evercore ISI Group | In Line | $18 → $17 |
| Jan-20-26 | Reiterated | Truist Securities | Buy | $19 → $20 |
| Aug-13-25 | Reiterated | Truist Securities | Buy | $23 → $19 |
| Oct-31-24 | Reiterated | Piper Sandler | Neutral | $18 → $19 |
| Sep-16-24 | Upgrade | Evercore ISI Group | Underperform → In Line | $43 → $18 |
| Sep-09-24 | Reiterated | Piper Sandler | Neutral | $18 |
| Jul-31-24 | Downgrade | Evercore ISI Group | In Line → Underperform |
Latest News· Times ET
Oct-27-26
Oct-21-26
Oct-21-2607:01AM
Oct-14-26
Oct-14-2606:27PM
Oct-12-26
Oct-12-2606:31AM
Oct-07-26
Oct-02-26
Oct-02-2608:20PM
Oct-01-26
Oct-01-2604:15AM
Sep-30-26
Sep-30-2606:15AM
02:29AM
Sep-21-26
Sep-21-2606:23AM
Sep-07-26
Aug-31-26
Aug-31-2603:21AM
Aug-21-26
Aug-18-26
Aug-13-26
Company
Community Healthcare Trust Incorporated is a real estate investment trust. It focuses on owning income-producing real estate properties associated primarily with the delivery of outpatient healthcare services in our target sub-markets throughout the United States. As of December 31, 2025, the Company had investments of approximately 1.2 billion US dollars in 198 real estate properties (including one property with sales-type leases and one property classified as held for sale). The properties are in 36 states, totaling approximately 4.5 million square feet in the aggregate. Community Healthcare Trust Incorporated was incorporated in 2014 in Maryland, USA.
Ownership
Per-holder 13F data hasn't been ingested for this ticker yet.
Financial Statements
DataTimeframe
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 125 | 121 | 116 | 113 | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 46 | 111 | 23 | 21 | — | — | — | — | — | |
| Gross Profit | 78 | 10 | 93 | 92 | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 26 | 25 | 19 | 27 | — | — | — | — | — | |
| Research and Development | 0 | 0 | 0 | 0 | — | — | — | — | — | |
| Other Operating Expense | 5 | -35 | 54 | 40 | — | — | — | — | — | |
| Operating Income | 48 | 20 | 20 | 25 | — | — | — | — | — | |
| Interest Expense | 31 | 34 | 24 | 18 | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | 3 | 19 | 0 | 1 | — | — | — | — | — | |
| Net Income Before Taxes | 21 | 5 | -3 | 8 | — | — | — | — | — | |
| Income Taxes | 0 | 0 | 0 | 0 | — | — | — | — | — | |
| Consolidated Net Income | 21 | 5 | -3 | 8 | — | — | — | — | — | |
| Net Income From Continuing Operations | 21 | 5 | -3 | 8 | — | — | — | — | — | |
| Net Income | 21 | 5 | -3 | 8 | — | — | — | — | — | |
| EPS (Recurring) | 0.67 | 0.08 | -0.23 | 0.20 | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 0.67 | 0.08 | -0.23 | 0.20 | — | — | — | — | — | |
| EPS (Diluted) | 0.67 | 0.08 | -0.23 | 0.20 | — | — | — | — | — | |
| EBITDA | 96 | 83 | 63 | 66 | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 19.49 | 212.14 | — | 133.20 | — | — | — | — | — | |
| Price To Sales Ratio | 2.82 | 3.66 | 4.47 | 5.89 | — | — | — | — | — | |
| Gross Margin | 62.40 | 8.26 | 80.17 | 81.42 | — | — | — | — | — | |
| Operating Margin | 38.40 | 16.53 | 17.24 | 22.12 | — | — | — | — | — | |
| Net Margin | 16.80 | 4.13 | -2.59 | 7.08 | — | — | — | — | — | |
| Shares Outstanding | 27 | 27 | 27 | 25 | — | — | — | — | — | |
| Market Capitalization | 353 | 443 | 519 | 666 | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
Unlock full historical data
See years of past statements with Premium.
Insider Trading Volume
Insider Trading
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Dupuy David H. | CEO and President | Aug 14 '26 | Buy | 15.13 | 10,000 | 151,300 | 557,262 | Aug 17 |
| Hensley Robert Z | Director | Aug 11 '26 | Buy | 15.21 | 8,000 | 121,680 | 103,702 | Aug 12 |
| Cotman Cathrine | Director | Nov 04 '25 | Buy | 14.66 | 4,000 | 58,640 | 37,635 | Nov 05 |
| Van Horn R. Lawrence | Director | May 28 '25 | Buy | 16.37 | 11,815 | 193,412 | 88,502 | May 30 |
| Dupuy David H. | CEO and President | May 13 '25 | Buy | 16.23 | 10,000 | 162,300 | 458,500 | May 14 |
| Cotman Cathrine | Director | Apr 30 '25 | Sale | 17.09 | 3,000 | 51,270 | 20,861 | May 02 |
| Cotman Cathrine | Director | Apr 30 '25 | Buy | 17.10 | 3,000 | 51,300 | 23,861 | May 02 |
| Van Horn R. Lawrence | Director | Sep 09 '24 | Buy | 16.13 | 10,000 | 161,300 | 62,230 | Sep 10 |
| Cotman Cathrine | Director | Aug 13 '24 | Buy | 17.72 | 2,000 | 35,440 | 20,861 | Aug 14 |
| Hensley Robert Z | Director | Aug 05 '24 | Buy | 19.50 | 6,500 | 126,750 | 70,670 | Aug 06 |
| Van Horn R. Lawrence | Director | Aug 05 '24 | Buy | 19.42 | 2,500 | 48,550 | 52,230 | Aug 06 |
| Dupuy David H. | CEO and President | Aug 05 '24 | Buy | 19.48 | 10,000 | 194,800 | 363,565 | Aug 06 |
| Cotman Cathrine | Director | Mar 10 '23 | Buy | 36.24 | 277 | 10,038 | 5,155 | Mar 13 |
| Van Horn R. Lawrence | Director | Mar 10 '23 | Buy | 36.43 | 685 | 24,955 | 34,193 | Mar 13 |
| GULMI CLAIRE M | Director | Mar 09 '23 | Buy | 36.77 | 2,042 | 75,084 | 26,140 | Mar 13 |
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.